• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激动剂和拮抗剂在 5-HT₃A 和 5-HT₃AB 受体中诱导不同的帕洛诺司琼解离速率。

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.

机构信息

Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK.

出版信息

Neuropharmacology. 2013 Oct;73:241-6. doi: 10.1016/j.neuropharm.2013.05.010. Epub 2013 Jun 5.

DOI:10.1016/j.neuropharm.2013.05.010
PMID:23747573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778450/
Abstract

Palonosetron is a potent 5-HT₃ receptor antagonist with a unique structure and some unusual properties. Here we explore the properties of palonosetron at heterologously expressed 5-HT₃A and 5-HT₃AB receptors. We used receptors expressed in HEK293 cells, and functionally analysed them using a membrane potential sensitive dye in a Flexstation, which revealed IC₅₀s of 0.24 nM and 0.18 nM for 5-HT₃A and 5-HT₃AB receptors respectively. Radioligand binding studies with [(3)H]palonosetron revealed similar Kds: 0.34 nM for 5-HT3A and 0.15 nM for 5-HT₃AB receptors. Kinetic studies showed palonosetron association and dissociation rates were slightly faster in 5-HT₃AB than 5-HT₃A receptors, and for both subtypes dissociation rates were ligand-dependent, with antagonists causing more rapid dissociation than agonists. Similar ligand effects were not observed for [(3)H]granisetron dissociation studies. These data support previous studies which show palonosetron has actions distinct to other 5-HT3 receptor antagonists, and the slow rates observed for agonist induced dissociation (t₁/₂ > 10 h) could at least partly explain the long duration of palonosetron effects in vivo.

摘要

帕洛诺司琼是一种具有独特结构和一些不寻常特性的强效 5-HT₃受体拮抗剂。在这里,我们探索了帕洛诺司琼在异源表达的 5-HT₃A 和 5-HT₃AB 受体上的性质。我们使用在 HEK293 细胞中表达的受体,并使用 Flexstation 中的膜电位敏感染料对其进行功能分析,结果显示 5-HT₃A 和 5-HT₃AB 受体的 IC₅₀ 分别为 0.24 nM 和 0.18 nM。用 [(3)H]帕洛诺司琼进行放射性配体结合研究显示出相似的 Kd 值:5-HT3A 为 0.34 nM,5-HT₃AB 为 0.15 nM。动力学研究表明,帕洛诺司琼与 5-HT₃AB 受体的结合和解离速率比 5-HT₃A 受体略快,对于这两种亚型,解离速率均依赖于配体,拮抗剂比激动剂导致更快的解离。对于 [(3)H]granisetron 解离研究,没有观察到类似的配体效应。这些数据支持先前的研究,表明帕洛诺司琼的作用与其他 5-HT3 受体拮抗剂不同,并且观察到激动剂诱导的解离(t₁/₂ > 10 h)的缓慢速率至少部分解释了帕洛诺司琼在体内作用的持续时间长的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/dd6ff61706c3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/bbfc091558a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/1e0c07a86096/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/15d6a79f7b91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/e16ffb0f0728/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/c94f3198a5ed/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/dd6ff61706c3/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/bbfc091558a7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/1e0c07a86096/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/15d6a79f7b91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/e16ffb0f0728/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/c94f3198a5ed/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1cf/3778450/dd6ff61706c3/gr6.jpg

相似文献

1
Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.激动剂和拮抗剂在 5-HT₃A 和 5-HT₃AB 受体中诱导不同的帕洛诺司琼解离速率。
Neuropharmacology. 2013 Oct;73:241-6. doi: 10.1016/j.neuropharm.2013.05.010. Epub 2013 Jun 5.
2
Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.探索 5-HT(3) 受体中帕洛诺司琼的别构结合位点。
Bioorg Med Chem. 2013 Dec 1;21(23):7523-8. doi: 10.1016/j.bmc.2013.09.028. Epub 2013 Sep 20.
3
Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.帕洛诺司琼对5-HT₃受体的长期抑制是由表面受体抑制引起的,而非诱导受体内化。
Br J Pharmacol. 2013 Jul;169(6):1252-62. doi: 10.1111/bph.12204.
4
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.帕洛诺司琼与5-羟色胺3(5-HT3)受体表现出独特的分子相互作用。
Anesth Analg. 2008 Aug;107(2):469-78. doi: 10.1213/ane.0b013e318172fa74.
5
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.VUF10166,一种新型化合物,对 5-HT₃A 和 5-HT₃AB 受体具有不同的活性。
J Pharmacol Exp Ther. 2012 May;341(2):350-9. doi: 10.1124/jpet.111.190769. Epub 2012 Feb 3.
6
Palonosetron-5-HT Receptor Interactions As Shown by a Binding Protein Cocrystal Structure.帕洛诺司琼与 5-HT 受体相互作用的结合蛋白晶体结构。
ACS Chem Neurosci. 2016 Dec 21;7(12):1641-1646. doi: 10.1021/acschemneuro.6b00132. Epub 2016 Sep 22.
7
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.帕洛诺司琼触发 5-HT(3)受体内化,并导致受体功能的长期抑制。
Eur J Pharmacol. 2010 Jan 25;626(2-3):193-9. doi: 10.1016/j.ejphar.2009.10.002. Epub 2009 Oct 15.
8
Synthesis and Pharmacological Evaluation of [C]Granisetron and [F]Fluoropalonosetron as PET Probes for 5-HT Receptor Imaging.[C]格拉司琼和[F]氟帕洛诺司琼作为5-羟色胺受体成像PET探针的合成及药理评价
ACS Chem Neurosci. 2016 Nov 16;7(11):1552-1564. doi: 10.1021/acschemneuro.6b00192. Epub 2016 Sep 9.
9
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.强效选择性拮抗剂RS 25259-197与5-HT3受体在体外的相互作用。
Br J Pharmacol. 1995 Feb;114(4):851-9. doi: 10.1111/j.1476-5381.1995.tb13282.x.
10
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.止吐药 5-HT3 受体拮抗剂帕洛诺司琼在体外和体内抑制 P 物质介导的反应。
J Pharmacol Exp Ther. 2010 Nov;335(2):362-8. doi: 10.1124/jpet.110.166181. Epub 2010 Aug 19.

引用本文的文献

1
Focal pharmacological manipulation of serotonin signaling in the amygdala does not alter social behavior.对杏仁核中血清素信号进行局部药理学操纵不会改变社交行为。
Psychopharmacology (Berl). 2025 Jan;242(1):101-115. doi: 10.1007/s00213-024-06651-4. Epub 2024 Jul 18.
2
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition.了解你的分子:候选药物的药理学特征,以提高疗效并减少后期损耗。
Nat Rev Drug Discov. 2024 Aug;23(8):626-644. doi: 10.1038/s41573-024-00958-9. Epub 2024 Jun 18.
3
5-HT Receptor MX Helix Contributes to Receptor Function.

本文引用的文献

1
Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.帕洛诺司琼对5-HT₃受体的长期抑制是由表面受体抑制引起的,而非诱导受体内化。
Br J Pharmacol. 2013 Jul;169(6):1252-62. doi: 10.1111/bph.12204.
2
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.VUF10166,一种新型化合物,对 5-HT₃A 和 5-HT₃AB 受体具有不同的活性。
J Pharmacol Exp Ther. 2012 May;341(2):350-9. doi: 10.1124/jpet.111.190769. Epub 2012 Feb 3.
3
Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors.
5-HT 受体 MX 螺旋有助于受体功能。
ACS Chem Neurosci. 2022 Aug 3;13(15):2338-2345. doi: 10.1021/acschemneuro.2c00339. Epub 2022 Jul 22.
4
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.开发 3-(4-氯苯基)-1-(苯乙基)脲类似物作为大麻素 1 型受体的变构调节剂:RTICBM-189 具有脑穿透性,可减弱可卡因觅药行为的复燃。
J Med Chem. 2022 Jan 13;65(1):257-270. doi: 10.1021/acs.jmedchem.1c01432. Epub 2021 Dec 20.
5
A Single Mutation in the Outer Lipid-Facing Helix of a Pentameric Ligand-Gated Ion Channel Affects Channel Function Through a Radially-Propagating Mechanism.五聚体配体门控离子通道面向脂质外侧螺旋中的单个突变通过径向传播机制影响通道功能。
Front Mol Biosci. 2021 Apr 30;8:644720. doi: 10.3389/fmolb.2021.644720. eCollection 2021.
6
Structure, Function and Physiology of 5-Hydroxytryptamine Receptors Subtype 3.5-羟色胺受体亚型 3 的结构、功能和生理学。
Subcell Biochem. 2021;96:373-408. doi: 10.1007/978-3-030-58971-4_11.
7
High-resolution structures of multiple 5-HTR-setron complexes reveal a novel mechanism of competitive inhibition.多个5-羟色胺受体-血清素复合物的高分辨率结构揭示了一种竞争性抑制的新机制。
Elife. 2020 Oct 16;9:e57870. doi: 10.7554/eLife.57870.
8
Molecular mechanism of setron-mediated inhibition of full-length 5-HT receptor.赛洛特介导的全长 5-HT 受体抑制的分子机制。
Nat Commun. 2019 Jul 19;10(1):3225. doi: 10.1038/s41467-019-11142-8.
9
5-Hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to its subsequent release.慢性暴露期间5-羟色胺(5-HT)的细胞隔离会因其随后的释放而延迟5-HT3受体的再敏化。
J Biol Chem. 2014 Nov 14;289(46):32020-32029. doi: 10.1074/jbc.M114.594796. Epub 2014 Oct 3.
10
Effects of pretreatment with intravenous palonosetron for propofol-remifentanil-based anesthesia in breast and thyroid cancer surgery: a double-blind, randomized, controlled study.静脉注射帕洛诺司琼预处理对乳腺癌和甲状腺癌手术中丙泊酚-瑞芬太尼麻醉的影响:一项双盲、随机、对照研究。
Korean J Anesthesiol. 2014 Jul;67(1):13-9. doi: 10.4097/kjae.2014.67.1.13. Epub 2014 Jul 29.
半胱氨酸修饰揭示了在人异源5-HT3AB受体中哪些亚基形成配体结合位点。
J Physiol. 2011 Sep 1;589(17):4243-57. doi: 10.1113/jphysiol.2011.208439. Epub 2011 Jun 27.
4
5-HT(3) receptors: potential of individual isoforms for personalised therapy.5-HT(3) 受体:各亚型在个体化治疗中的潜力。
Curr Opin Pharmacol. 2011 Feb;11(1):81-6. doi: 10.1016/j.coph.2011.01.011. Epub 2011 Feb 21.
5
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.止吐药 5-HT3 受体拮抗剂帕洛诺司琼在体外和体内抑制 P 物质介导的反应。
J Pharmacol Exp Ther. 2010 Nov;335(2):362-8. doi: 10.1124/jpet.110.166181. Epub 2010 Aug 19.
6
Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.同源和异源五聚体 5-HT3 受体配体识别位点的计算分析。
Eur J Med Chem. 2010 Nov;45(11):4746-60. doi: 10.1016/j.ejmech.2010.07.039. Epub 2010 Jul 27.
7
5-HT(3) receptors: role in disease and target of drugs.5-HT(3) 受体:在疾病中的作用和药物靶点。
Pharmacol Ther. 2010 Oct;128(1):146-69. doi: 10.1016/j.pharmthera.2010.07.001. Epub 2010 Jul 16.
8
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.激动剂和拮抗剂与 5-HT3AB 异源二聚体受体中的 A-A 界面结合。
Biophys J. 2010 Apr 21;98(8):1494-502. doi: 10.1016/j.bpj.2009.12.4313.
9
Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function.5-羟色胺3C、5-羟色胺3D和5-羟色胺3E受体亚基的特性:进化、分布及功能
J Neurochem. 2009 Jan;108(2):384-96. doi: 10.1111/j.1471-4159.2008.05775.x. Epub 2008 Nov 29.
10
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.帕洛诺司琼与5-羟色胺3(5-HT3)受体表现出独特的分子相互作用。
Anesth Analg. 2008 Aug;107(2):469-78. doi: 10.1213/ane.0b013e318172fa74.